Viewing Study NCT04103450


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-02-28 @ 10:23 PM
Study NCT ID: NCT04103450
Status: COMPLETED
Last Update Posted: 2024-08-21
First Post: 2019-09-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Sponsor: Urovant Sciences GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Overactive Bladder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Overactive Bladder View
None Benign Prostatic Hyperplasia View
None Vibegron View
None Beta-3 adrenergic receptor (β3-AR) View
None β3-AR agonist View